RE:RE:RE:RE:The pressure is on for Big Pharma...& Onc.Now that I have been thinking about it.
China's CDE (Center for Drug Evaluation) might be another avenue to explore. Tecentriq is approved in China for SCLC. After the posters on Tuesday, they might be able to apply for breakthrough therapy in China for both mBC & PDAC.
Yes, idle Sunday morning speculation, but the mind boggles when one thinks about the potential market.